BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9048424)

  • 1. Effective use of free thiols as scavengers for HF cocktails to deprotect bromo- and chloroacetylated synthetic peptides.
    Ivanov BB; Robey FA
    Pept Res; 1996; 9(6):305-7. PubMed ID: 9048424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and facile cyclization of N-chloroacetylated peptides from the C4 domain of HIV Gp120 in LiCl/DMF solvent systems.
    Robey FA
    J Pept Res; 2000 Sep; 56(3):115-20. PubMed ID: 11007268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements to the TMSBr method of peptide resin deprotection and cleavage: application to large peptides.
    Sparrow JT; Monera OD
    Pept Res; 1996; 9(5):218-22. PubMed ID: 9000246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprotection of Nin-formyl tryptophan using 1,2-ethanedithiol in liquid hydrogen fluoride. Deformylation upon HF treatment of Merrifield peptidyl-resins.
    Matsueda GR
    Int J Pept Protein Res; 1982 Jul; 20(1):26-34. PubMed ID: 7118426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient chemical method for dephosphorylation of phosphopeptides.
    Kuyama H; Toda C; Watanabe M; Tanaka K; Nishimura O
    Rapid Commun Mass Spectrom; 2003; 17(13):1493-6. PubMed ID: 12820217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
    Laman JD; Schellekens MM; Paddenburg D; Tersmette M; Langedijk JP; Boersma WJ; Claassen E
    Year Immunol; 1993; 7():63-8. PubMed ID: 7690509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Theoretical study of peptide spatial structure--fragments of the base antigenic determinant of HIV-1 gp120 protein. I. Peptides rp142 and rp342].
    Andrianov AM
    Mol Biol (Mosk); 1997; 31(5):861-71. PubMed ID: 9454072
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of a vaccine preparation representing the variable regions of the HIV type 1 envelope glycoprotein.
    Carlos MP; Anderson DE; Gardner MB; Torres JV
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):153-61. PubMed ID: 10659054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembly of cyclic peptides on a dendrimer: multiple cyclic antigen peptides.
    Spetzler JC; Tam JP
    Pept Res; 1996; 9(6):290-6. PubMed ID: 9048422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epimerization-free C-terminal peptide activation.
    Popovic S; Bieräugel H; Detz RJ; Kluwer AM; Koole JA; Streefkerk DE; Hiemstra H; van Maarseveen JH
    Chemistry; 2013 Dec; 19(50):16934-7. PubMed ID: 24307358
    [No Abstract]   [Full Text] [Related]  

  • 11. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
    Chersi A; Pugliese O; Federico A; Viora M
    Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput synthesis of peptide α-thioesters: a safety catch linker approach enabling parallel hydrogen fluoride cleavage.
    Brust A; Schroeder CI; Alewood PF
    ChemMedChem; 2014 May; 9(5):1038-46. PubMed ID: 24591329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidine-Protected β-Thiol Asparagine: Applications in One-Pot Ligation-Desulfurization Chemistry.
    Sayers J; Thompson RE; Perry KJ; Malins LR; Payne RJ
    Org Lett; 2015 Oct; 17(19):4902-5. PubMed ID: 26398220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement and induction of HIV-1 infection through an assembled peptide derived from the CD4 binding site of gp120.
    Groß A; Rödel K; Kneidl B; Donhauser N; Mössl M; Lump E; Münch J; Schmidt B; Eichler J
    Chembiochem; 2015 Feb; 16(3):446-54. PubMed ID: 25639621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated synthesis and use of N-chloroacetyl-modified peptides for the preparation of synthetic peptide polymers and peptide-protein immunogens.
    Lindner W; Robey FA
    Int J Pept Protein Res; 1987 Dec; 30(6):794-800. PubMed ID: 3440702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theoretical conformational NMR-analysis of RP342 peptide, affiliated with the immunogenic fragment of HIV-1 gp120 protein].
    Andrianov AM
    Dokl Akad Nauk; 1995 Oct; 344(4):546-8. PubMed ID: 8590869
    [No Abstract]   [Full Text] [Related]  

  • 19. Stabilization of the biologically active conformation of the principal neutralizing determinant of HIV-1(IIIB) containing a cis-proline surrogate: 1H NMR and molecular modeling study.
    Garcia J; Dumy P; Rosen O; Anglister J
    Biochemistry; 2006 Apr; 45(13):4284-94. PubMed ID: 16566603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side reaction of pyrenylalanine-peptides containing NG-tosylarginine during detosylation with hydrogen fluoride.
    Nakamura H; Lee S; Ono S; Kato T; Aoyagi H
    Int J Pept Protein Res; 1990 Nov; 36(5):471-5. PubMed ID: 2276875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.